Global Thematic Partners’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-333,304
Closed -$14.1M 24
2020
Q1
$14.1M Sell
333,304
-17,082
-5% -$882K 1.14% 41
2019
Q4
$21.3M Buy
350,386
+5,764
+2% +$315K 1.31% 36
2019
Q3
$16.2M Sell
344,622
-75,883
-18% -$3.63M 1.13% 37
2019
Q2
$19.8M Sell
420,505
-48,020
-10% -$1.92M 1.06% 39
2019
Q1
$16.7M Buy
468,525
+20,045
+4% +$693K 0.78% 45
2018
Q4
$12.8M Sell
448,480
-48,796
-10% -$1.7M 0.7% 45
2018
Q3
$22.1M Buy
497,276
+232,362
+88% +$12.2M 0.87% 43
2018
Q2
$15.6M Sell
264,914
-86,626
-25% -$4.93M 0.57% 50
2018
Q1
$16.1M Sell
351,540
-281,912
-45% -$11.6M 0.55% 49
2017
Q4
$14.9M Buy
633,452
+63,611
+11% +$1.21M 0.49% 49
2017
Q3
$10.2M Buy
+569,841
New +$10.3M 0.33% 55

Other funds holding CRSP